HT Af
Conditions
Interventions
None listed
Sponsors
Department of Cardiology University Northern Yokohama Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: HT After pacemaker implantation
Exclusion criteria
Exclusion criteria: (1) When the research subject requests discontinuation. (2) When the research is interrupted for reasons attributable to the research subject (e.g., moving, changing doctors or hospitals, busy schedule, inability to follow up, etc.) (3) When it is found that the research subject is not a target case after the research has begun. (4) In the event of an accidental incident (5) When an adverse event occurs (including exacerbation of the underlying disease, complications, or accident) and the investigator determines that the study should be terminated (6) When it becomes difficult to continue the research due to inadequate efficacy or worsening of symptoms (7) When there is a serious deviation from the research protocol and it is judged that the research cannot be evaluated (8) When it is found that the research subject is not taking the medication as instructed by the physician in charge of the research (9) Other cases in which the investigator determines that the continuation of the research is difficult and that discontinuation is appropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to atrial fibrillation onset | — |
Secondary
| Measure | Time frame |
|---|---|
| Atrial fibrillation 6, 12, 18, 24 months after surgery Change in parameters AP VP battery voltage A, Vlead resistance, threshold, wave height AFburden at 24 months after pacemaker implantation Total number of supraventricular extrasystoles Supraventricular extrasystoles short run atrial tachycardia 6,12,18,24 months after surgery Change from baseline in resting heart rate 6, 12, 18, and 24 months after surgery Change from baseline in the following biochemical tests 6,12,18,24 months after surgery Neutral fat, LDL,HDL cholesterol, fatty acid quartiles, hemoglobin, hematocrit, cystatin C, renin, aldosterone, Brain natriuretic peptide, Atrial natriuretic peptide, NT-pro BNP | — |
Countries
Japan
Contacts
Public Contactmorio ono
Showa University Northern Yokohama Hospital Cardiology
Outcome results
None listed